ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC Holdings

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC is an investment fund managing more than 906.16M US dollars. The largest holdings include Third Harmonic Bio, Day One Biopharmaceuticals and Kymera Therapeutics. In Q3 2022 the fund bought assets of total value of 206.92M US dollars and sold assets of total value of 10.79M US dollars.

$906.16M

portfolio value

+27.77%

quarter

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2022	41033000	516000
Q2 2022	79173000	17054000
Q3 2022	206922000	10790000

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 22.84% Portfolio value: 206.92M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	22.84%	206.92M	N/A	$22	N/A	N/A Q3 2022
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 18.06% Portfolio value: 163.62M Avg. open price: $9.92 Current price: $21.45 P/L: +116.23% Sold -8.91% shares Q3 2022	share	18.06%	163.62M	$9.92	$21.45	+116.23%	Sold -8.91% shares Q3 2022
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 16.52% Portfolio value: 149.68M Avg. open price: N/A Current price: $29.11 P/L: N/A N/A Q4 2021	share	16.52%	149.68M	N/A	$29.11	N/A	N/A Q4 2021
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 12.52% Portfolio value: 113.47M Avg. open price: N/A Current price: $11.47 P/L: N/A N/A Q4 2021	share	12.52%	113.47M	N/A	$11.47	N/A	N/A Q4 2021
Biotechnology Replimune Group, Inc. Portfolio share: 5.92% Portfolio value: 53.68M Avg. open price: N/A Current price: $19.95 P/L: N/A Sold -3.16% shares Q3 2022	share	5.92%	53.68M	N/A	$19.95	N/A	Sold -3.16% shares Q3 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 5.86% Portfolio value: 53.11M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q1 2022	share	5.86%	53.11M	N/A	$12	N/A	N/A Q1 2022
Biotechnology Generation Bio Co. Portfolio share: 4.85% Portfolio value: 43.96M Avg. open price: N/A Current price: $5.22 P/L: N/A N/A Q4 2021	share	4.85%	43.96M	N/A	$5.22	N/A	N/A Q4 2021
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 4.26% Portfolio value: 38.59M Avg. open price: N/A Current price: $18 P/L: N/A Sold -11.76% shares Q3 2022	share	4.26%	38.59M	N/A	$18	N/A	Sold -11.76% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 3.74% Portfolio value: 33.85M Avg. open price: N/A Current price: $44.04 P/L: N/A Sold -55.46% shares Q3 2022	share	3.74%	33.85M	N/A	$44.04	N/A	Sold -55.46% shares Q3 2022
Biotechnology Ikena Oncology, Inc. Portfolio share: 1.97% Portfolio value: 17.81M Avg. open price: N/A Current price: $2.23 P/L: N/A N/A Q4 2021	share	1.97%	17.81M	N/A	$2.23	N/A	N/A Q4 2021
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 0.95% Portfolio value: 8.61M Avg. open price: N/A Current price: $1.7 P/L: N/A N/A Q4 2021	share	0.95%	8.61M	N/A	$1.7	N/A	N/A Q4 2021
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.89% Portfolio value: 8.03M Avg. open price: N/A Current price: $2.43 P/L: N/A N/A Q4 2021	share	0.89%	8.03M	N/A	$2.43	N/A	N/A Q4 2021
Biotechnology Magenta Therapeutics, Inc. Portfolio share: 0.54% Portfolio value: 4.90M Avg. open price: N/A Current price: $1.24 P/L: N/A N/A Q4 2021	share	0.54%	4.90M	N/A	$1.24	N/A	N/A Q4 2021
Biotechnology F-star Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 3.07M Avg. open price: N/A Current price: $5.55 P/L: N/A N/A Q4 2021	share	0.34%	3.07M	N/A	$5.55	N/A	N/A Q4 2021
Biotechnology AVROBIO, Inc. Portfolio share: 0.32% Portfolio value: 2.90M Avg. open price: N/A Current price: $0.89 P/L: N/A N/A Q4 2021	share	0.32%	2.90M	N/A	$0.89	N/A	N/A Q4 2021
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 2.06M Avg. open price: N/A Current price: $1.89 P/L: N/A N/A Q4 2021	share	0.23%	2.06M	N/A	$1.89	N/A	N/A Q4 2021
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 1.84M Avg. open price: N/A Current price: $26.84 P/L: N/A N/A Q4 2021	share	0.20%	1.84M	N/A	$26.84	N/A	N/A Q4 2021

Showing TOP 17 ATLAS VENTURE LIFE SCIENCE ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?

The biggest position of the ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC is Third Harmonic Bio, Inc. (THRD) with 22.84% portfolio share worth of 206.92M US dollars.

Top 5 ATLAS VENTURE LIFE SCIENCE ADVISORS's holdings represent 75.86% of the portfolio:

Third Harmonic Bio, Inc. (THRD) – 22.84%
Day One Biopharmaceuticals, Inc. (DAWN) – 18.06%
Kymera Therapeutics, Inc. (KYMR) – 16.52%
Dyne Therapeutics, Inc. (DYN) – 12.52%
Replimune Group, Inc. (REPL) – 5.92%

Who is the portfolio manager of ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?

The portfolio manager of the ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC is .

What is the total asset value of the ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC portfolio?

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC total asset value (portfolio value) is 906.16M US dollars.

Who is ?

is the portfolio manager of the ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC.

What is (ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC) fund performance?

ATLAS VENTURE LIFE SCIENCE ADVISORS's quarterly performance is +27.77%, annualy 0.00%.

What is the ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC CIK?

ATLAS VENTURE LIFE SCIENCE ADVISORS's Central Index Key is 0001917529 .